Published in

Wiley Open Access, Journal of Cellular and Molecular Medicine, 2021

DOI: 10.1111/jcmm.16513

Links

Tools

Export citation

Search in Google Scholar

Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO